Company News Summary
CSL Provides an Update on COVID-19 Vaccine
11 Dec 2020 | 07:41:00 | Associate analysts | Increase | Decrease | 
Original announcement: Update on UQ-CSL v451 COVID-19 Vaccine
CSL provided an update on COVID-19 vaccine. The University of Qld (UQ) and the Company announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, following agreement with the Australian Government, it will not progress the vaccine candidate to Phase 2/3 clinical trials.
See more ASX300 News Announcements